A physIQ + OncoBay Webinar

Strategies to Expand Access to Immuno-Oncology Trials and Treatments

Wednesday, February 1st 2023

11am PST / 2pm EST

 

Barriers to access for immuno-oncology therapies like CAR-T are threatening the promise of these lifesaving treatments. A small number of approved therapies that often face manufacturing challenges, the limited number of treatment centers, the high costs, and the post-treatment monitoring requirements make bringing this miracle to market in a widely accessible way a serious challenge. 
 
OncoBay Clinical, a CRO specializing in complex immuno-oncology programs, has recently partnered with physIQ to make immuno-oncology trials, and ultimately marketed therapies, more accessible for patients through a predict-to-prevent safety monitoring solution using continuous remote patient data.
 
The webinar will include an explanation of the physIQ/OncoBay “physiology-first” data model and a demonstration of how physIQ’s continuous remote patient monitoring technology provides predictive patients insights for OncoBay’s clinical trial sponsors. We will also discuss how this improved immuno-oncology trial model can have positive results such as:

  • Increasing the likelihood of IRB and regulatory approval
  • Overcoming the geographical challenges of immuno-oncology trial participation
  • Keeping patients safe both in and out of traditional clinical care settings
  • Reducing the cost burden of immuno-oncology trials and therapy administration
  • Increasing immuno-oncology treatment capacity without increasing treatment centers

Click for a 1-minute Video Preview 

HubSpot Video

Please complete this form to register for the webinar.

Blue Rectangle

PANEL PARTICIPANTS

Edmondo Robinson, MD

Edmondo Robinson, MD, MBA, MS, FACP

Chief Digital Officer

Moffitt_Cancer_Center_Logo

 

 

Dannelle Palmer

Dannelle Palmer

Chief Operating Officer

OncoBay-Hor-Logo-Color-200p

 

 

Brandon Fletcher

Brandon Fletcher

Senior Director of Clinical Operations, Immuno-Oncology and Cell Therapeutics

OncoBay-Hor-Logo-Color-200p

 

Matt Pipke

Matt Pipke

Chief Digital Health Officer

physIQ

 

 

John Varaklis

John Varaklis

Chief Strategy Officer

physIQ